Folate receptor-mediated drug targeting: from therapeutics to diagnostics - PubMed (original) (raw)
Review
. 2005 Oct;94(10):2135-46.
doi: 10.1002/jps.20457.
Affiliations
- PMID: 16136558
- DOI: 10.1002/jps.20457
Review
Folate receptor-mediated drug targeting: from therapeutics to diagnostics
Andrew R Hilgenbrink et al. J Pharm Sci. 2005 Oct.
Abstract
Folate targeted drug delivery has emerged as an alternative therapy for the treatment and imaging of many cancers and inflammatory diseases. Due to its small molecular size and high binding affinity for cell surface folate receptors (FR), folate conjugates have the ability to deliver a variety of molecular complexes to pathologic cells without causing harm to normal tissues. Complexes that have been successfully delivered to FR expressing cells, to date, include protein toxins, immune stimulants, chemotherapeutic agents, liposomes, nanoparticles, and imaging agents. This review will summarize the applications of folic acid as a targeting ligand and highlight the various methods being developed for delivery of therapeutic and imaging agents to FR-expressing cells.
Copyright (c) 2005 Wiley-Liss, Inc. and the American Pharmacists Association
Similar articles
- Targeting therapeutic and imaging agents to folate receptor positive tumors.
Reddy JA, Allagadda VM, Leamon CP. Reddy JA, et al. Curr Pharm Biotechnol. 2005 Apr;6(2):131-50. doi: 10.2174/1389201053642376. Curr Pharm Biotechnol. 2005. PMID: 15853692 Review. - [Folate receptor-mediated antitumor drugs].
Zhao J, Cao SL, Zheng XL, Zhao B. Zhao J, et al. Yao Xue Xue Bao. 2009 Feb;44(2):109-14. Yao Xue Xue Bao. 2009. PMID: 19408677 Review. Chinese. - Folate-targeted chemotherapy.
Leamon CP, Reddy JA. Leamon CP, et al. Adv Drug Deliv Rev. 2004 Apr 29;56(8):1127-41. doi: 10.1016/j.addr.2004.01.008. Adv Drug Deliv Rev. 2004. PMID: 15094211 Review. - Targeted drug delivery via folate receptors.
Zhao X, Li H, Lee RJ. Zhao X, et al. Expert Opin Drug Deliv. 2008 Mar;5(3):309-19. doi: 10.1517/17425247.5.3.309. Expert Opin Drug Deliv. 2008. PMID: 18318652 Review. - The folate receptor as a molecular target for tumor-selective radionuclide delivery.
Ke CY, Mathias CJ, Green MA. Ke CY, et al. Nucl Med Biol. 2003 Nov;30(8):811-7. doi: 10.1016/s0969-8051(03)00117-3. Nucl Med Biol. 2003. PMID: 14698784 Review.
Cited by
- Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic.
Thomas TP, Joice M, Sumit M, Silpe JE, Kotlyar A, Bharathi S, Kukowska-Latallo J, Baker JR, Choi SK. Thomas TP, et al. Curr Pharm Des. 2013;19(37):6594-605. doi: 10.2174/1381612811319370004. Curr Pharm Des. 2013. PMID: 23621534 Free PMC article. - Targeted Delivery Methods for Anticancer Drugs.
Veselov VV, Nosyrev AE, Jicsinszky L, Alyautdin RN, Cravotto G. Veselov VV, et al. Cancers (Basel). 2022 Jan 26;14(3):622. doi: 10.3390/cancers14030622. Cancers (Basel). 2022. PMID: 35158888 Free PMC article. Review. - Self-assembled liposomal nanoparticles in photodynamic therapy.
Sadasivam M, Avci P, Gupta GK, Lakshmanan S, Chandran R, Huang YY, Kumar R, Hamblin MR. Sadasivam M, et al. Eur J Nanomed. 2013 Jul;5(3):10.1515/ejnm-2013-0010. doi: 10.1515/ejnm-2013-0010. Eur J Nanomed. 2013. PMID: 24348377 Free PMC article. - Folate receptor alpha as a tumor target in epithelial ovarian cancer.
Kalli KR, Oberg AL, Keeney GL, Christianson TJ, Low PS, Knutson KL, Hartmann LC. Kalli KR, et al. Gynecol Oncol. 2008 Mar;108(3):619-26. doi: 10.1016/j.ygyno.2007.11.020. Epub 2008 Jan 28. Gynecol Oncol. 2008. PMID: 18222534 Free PMC article. - Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery.
Vaughan HJ, Green JJ, Tzeng SY. Vaughan HJ, et al. Adv Mater. 2020 Apr;32(13):e1901081. doi: 10.1002/adma.201901081. Epub 2019 Jun 20. Adv Mater. 2020. PMID: 31222852 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical